- Home
- JCSE vs EVOK Comparison
JCSE vs EVOK Comparison
Compare JCSE & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- EVOK
- Stock Information
- Founded
- JCSE 1999
- EVOK 2007
- Country
- JCSE Singapore
- EVOK United States
- Employees
- JCSE N/A
- EVOK N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- JCSE Consumer Discretionary
- EVOK Health Care
- Exchange
- JCSE Nasdaq
- EVOK Nasdaq
- Market Cap
- JCSE 7.6M
- EVOK 7.4M
- IPO Year
- JCSE 2022
- EVOK 2013
- Fundamental
- Price
- JCSE $1.68
- EVOK $4.94
- Analyst Decision
- JCSE
- EVOK
- Analyst Count
- JCSE 0
- EVOK 0
- Target Price
- JCSE N/A
- EVOK N/A
- AVG Volume (30 Days)
- JCSE 26.7K
- EVOK 11.7K
- Earning Date
- JCSE 10-30-2024
- EVOK 03-13-2025
- Dividend Yield
- JCSE 5.33%
- EVOK N/A
- EPS Growth
- JCSE N/A
- EVOK N/A
- EPS
- JCSE 0.12
- EVOK N/A
- Revenue
- JCSE $14,723,999.00
- EVOK $8,617,036.00
- Revenue This Year
- JCSE N/A
- EVOK $97.35
- Revenue Next Year
- JCSE N/A
- EVOK $99.52
- P/E Ratio
- JCSE $13.69
- EVOK N/A
- Revenue Growth
- JCSE N/A
- EVOK 100.35
- 52 Week Low
- JCSE $0.60
- EVOK $3.54
- 52 Week High
- JCSE $2.39
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- JCSE 67.11
- EVOK 58.52
- Support Level
- JCSE $1.43
- EVOK $4.22
- Resistance Level
- JCSE $1.58
- EVOK $5.28
- Average True Range (ATR)
- JCSE 0.08
- EVOK 0.31
- MACD
- JCSE 0.03
- EVOK 0.06
- Stochastic Oscillator
- JCSE 93.94
- EVOK 67.92
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.